Front 2011 summer

The Voice

Many of us in the industry have heard it or have said it: BioAlberta is the voice of the life...

Read More ›› Wednesday, February 26 2014

Zenith Epigenetics Corp., a research and development biotechnology company, based in Calgary, is finding new ways to treat and potentially cure certain cancers. Zenith’s focus is on inhibiting BET (Bromodomain and ExtraTerminal domain) proteins to understand and manipulate genes that are directly related to certain types of cancer, autoimmune disease and cardiovascular disease.

Gold Partners

McCarthy Tetrault

Silver Partners

   AbbVie   •
   AMGEN   •
   AVAC Ltd.   •
   Eli Lilly   •
   EMD   •
   Janssen   •
   Novartis    •
   Sanofi    •